Delcath Systems (STU:DV3R) Cyclically Adjusted PB Ratio: (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:DV3R Delcath Systems Inc STU:DV3R
73 GF Score
Price €14.36
GF Value €25.64
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Delcath Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Delcath Systems  (STU:DV3R) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Delcath Systems Cyclically Adjusted PB Ratio Related Terms


Delcath Systems Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Delcath Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems Cyclically Adjusted PB Ratio Chart

Delcath Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Delcath Systems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:DV3R vs PACB, CLPT, SI: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Delcath Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delcath Systems Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Cyclically Adjusted PB Ratio falls into.


STU:DV3R
73GF Score
Delcath Systems Inc STU:DV3R
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delcath Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Delcath Systems's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Delcath Systems's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.036/333.9520*333.9520
=3.036

Current CPI (Jun. 2026) = 333.9520.

Delcath Systems Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 -776.000 246.819 -1,049.947
201712 286.500 246.524 388.105
201803 -5,030.000 249.554 -6,731.123
201806 -11,205.000 251.989 -14,849.585
201809 -521.125 252.439 -689.397
201812 -875.400 251.233 -1,163.627
201903 -1,002.048 254.202 -1,316.417
201906 -1,011.923 256.143 -1,319.317
201909 -657.423 256.759 -855.073
201912 -85.388 256.974 -110.966
202003 -99.247 258.115 -128.407
202006 1.942 257.797 2.516
202009 0.689 260.280 0.884
202012 3.027 260.474 3.881
202103 2.688 264.877 3.389
202106 1.712 271.696 2.104
202109 1.355 274.310 1.650
202112 1.338 278.802 1.603
202203 0.600 287.504 0.697
202206 -0.340 296.311 -0.383
202209 -0.616 296.808 -0.693
202212 -0.551 296.797 -0.620
202303 -1.211 301.836 -1.340
202306 -0.015 305.109 -0.016
202309 1.176 307.789 1.276
202312 0.636 306.746 0.692
202403 0.529 312.332 0.566
202406 0.139 314.175 0.148
202409 0.276 315.301 0.292
202412 1.986 315.605 2.101
202503 2.219 319.799 2.317
202506 2.604 322.561 2.696
202509 2.771 324.800 2.849
202512 2.738 324.054 2.822
202603 2.829 330.213 2.861
202606 3.036 333.952 3.036

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Delcath Systems (STU:DV3R) Overvalued in 2026?

Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued. The current stock price of €14.36 is trading 44% below its estimated GF Value™ of €25.64. GuruFocus considers Delcath Systems to be Significantly Undervalued.

Key valuation signals for STU:DV3R:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €25.64 vs. price of €14.36 (44% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the STU:DV3R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Delcath Systems Business Description

Other Exchanges DCTH:USA
Address 566 Queensbury Avenue, Queensbury, NY, USA, 12804
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
73GF Score

Get the complete analysis for STU:DV3R

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.36
Price
€25.64
GF Value